Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Health Outcomes: Physicians Interactive acquires Univadis, rebrands as Aptus Health

The digital HCP engagement provider Physicians Interactive announced two major strategic moves in the past two months, acquiring the HCP content platform Univadis from Merck in October and then rebranding itself as Aptus Health in November. Univadis, previously a wholly owned subsidiary of Merck, has an active membership of more than 3 million HCPs in […]

Read More »

Docs, and patients, should remember to use generics

(Reuters Health) – Prescribing generic medicines instead of brand name drugs whenever possible cuts costs, improves patient adherence and improves health outcomes, according to a new recommendation from the American College of Physicians. “Generic medications are cheaper and patients are more likely to get those prescriptions filled,” said Dr. Amir Qaseem of the American College […]

Read More »

Physicians Interactive Advances Global Health Digital Engagement by Acquiring Univadis

Authoritative Medical Content Platform Combined with Deep Digital Expertise Offers Greater Opportunities to Engage Healthcare Professionals and Improve Outcomes   READING, Mass., Oct. 21, 2015 /PRNewswire/ — Physicians Interactive® (PI) announced today the launch of its recently acquired Univadis platform, the world’s largest healthcare professional (HCP) network. Univadis, previously a wholly-owned subsidiary of Merck (known […]

Read More »

Xerox Expands Pharma Portfolio with Acquisition of inVentiv Patient Access Solutions

NORWALK, Conn. & BURLINGTON, Mass.–(BUSINESS WIRE)–Xerox (NYSE:XRX) and inVentiv Health today announced Xerox’s acquisition of inVentiv Patient Access Solutions (iPAS), an inVentiv Health company. The acquisition will expand Xerox’s pharmacy solutions portfolio with an offering to help pharmaceutical companies drive product adoption and support patients in minimizing or eliminating financial and reimbursement hurdles. iPAS serves […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom